1-methyl-4-phenylpyridinium has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, JD; Bacon, JP; Johannessen, JN; Markey, SP; Schuller, HM | 1 |
1 other study(ies) available for 1-methyl-4-phenylpyridinium and Liver Dysfunction
Article | Year |
---|---|
1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Chemical and Drug Induced Liver Injury; Edema; Female; Glutathione; Kidney Diseases; Kinetics; Liver Diseases; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Selenium | 1986 |